LONDON, UK / ACCESSWIRE / June 13, 2016 / ActiveWallSt.com announces the list of stocks for today’s research coverage. Pre-market the Active Wall St. team provides the latest corporate, market and technical events impacting selected stocks on the Oil & Gas Drilling & Exploration industry. Companies recently under review include Petroleo Brasileiro, Ensco, Noble, and Patterson-UTI Energy. Register with us now for your free membership and see our complete reports on these equities at:

http://www.activewallst.com/register/

Today, ActiveWallSt.com is promoting its equity research coverage. Get all of our research report free by signing up to http://www.activewallst.com/register/.

Firms in the Oil and Gas Drilling and Exploration industry are operating in a very challenged and unsteady environment. Let us see how this is affecting some of the big names in the industry. Know more about these equities by accessing their full report for free at:

http://www.activewallst.com/register/

ActiveWallSt.com takes a brief technical look at how each of the companies mentioned above have fared over the last few trading sessions.

Petroleo Brasileiro S.A. (NYSE: PBR-A)

Last Friday at the close, shares in Rio de Janeiro, Brazil-based integrated energy Company, Petroleo Brasileiro S.A., ended at $5.09, which was a correction of 4.86%. The stock recorded a trading volume of 10.10 million shares. The Company’s shares have advanced 14.38% in the previous three months and 49.71% on an YTD basis. The stock is trading above its 200-day moving average by 27.82%. Furthermore, shares of Petroleo Brasileiro have a Relative Strength Index (RSI) of 50.42.

Ensco PLC (NYSE: ESV)

London, United Kingdom headquartered offshore contract drilling services provider, Ensco PLC’s stock finished Friday’s session 6.32% lower at $10.53 and with a total volume of 5.07 million shares traded. The Company’s shares are trading above their 50-day moving average by 0.83%. The stock has an RSI of 51.55.

Noble Corp. PLC (NYSE: NE)

Shares in London, United Kingdom headquartered offshore drilling contractor, Noble Corp. PLC saw a correction of 4.99%, to end the session at $9.14 with a total volume of 6.54 million shares traded. The stock is trading below its 50-day moving average by 6.17%. The Company’s shares have an RSI of 50.16.

Patterson-UTI Energy Inc. (NASDAQ: PTEN)

Houston, Texas-based Patterson-UTI Energy Inc.’s stock recorded a trading volume of 2.95 million shares and closed the day 2.95% lower at $21.07. The Company’s shares have gained 18.09% in the past month, 17.76% in the previous three months, and 40.62% on an YTD basis. The stock is trading 15.66% above its 50-day moving average and 34.29% above its 200-day moving average. Additionally, shares of Patterson-UTI Energy, which through its subsidiaries provides onshore contract drilling services, have an RSI of 66.51. On June 01st, 2016, research firm Credit Suisse downgraded the Company’s stock rating from ‘Neutral’ to ‘Underperform’.

Active Wall Street

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number: 1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441062

TORONTO, ON / ACCESSWIRE / June 13, 2016 / Wi2Wi Corporation (Wi2Wi or the Company) (TSXV: YTY), a leading global developer and manufacturer of wireless connectivity solutions, high precision frequency control, timing, and microwave filter devices, is pleased to announce a Low power BLE module WE7220B0, the first product from its embedded series of products.

WE7220B0 module with integrated antenna provides everything required to create a Bluetooth low energy product. It integrates Low Noise Amplifier, Power Amplifier, RF switch, Baluns, baseband, crystals, filter, Microcontroller, qualified Bluetooth v4.1 stack, allowing reduced design cost, complexity, and faster time to market for the customer. With a Packet-by-packet automatic gain control, this module allows the end system to work with improved performance, even in a high interference environment. The best in class small form factor, and cost effective WE7220B0, using advanced power management features and consuming <1uA of current in dormant mode, with enhanced range, and low latency data transfers, is ideal for a range of applications, including in-home medical devices, home automation devices like smart switches, smart plugs, smart remotes, temperature, humidity and air quality sensors, and wearable health and fitness sensors like step counters, pulse monitors, heart rate monitors, and blood pressure monitors that can run for months or even years on a coin cell battery, or even on energy harvesting.

By completely integrating all the needed hardware and BLE software stack with ATT, GATT, SMP, L2CAP, GAP profiles and sample applications, WE7220B0 will simplify BLE system integration to the point where even those with little software or Bluetooth expertise can develop fully functional applications very quickly, and substantially reduce the time to market and product cost. The production units will be fully certified for FCC, CE, and IC and comes with out of the box integration tools with all the required protocol stacks, extensive software libraries, and sample applications. Productions units will be available by late 3Q2016.

“We are really excited to announce WE7220B0, a single mode BLE module with antenna, with industries best form factor, performance, and power consumption. WE7220B0 can be used by our customers in a myriad of IoT applications like wearables, lighting, and sensors, with fast and easy integration, which reduces their development cost and time to market,” said Ramesh Duvvuru, VP of Engineering and Wireless Connectivity.

“We are excited about the release of WE7220B0 which addresses the low power and cost effective BLE solutions the industry is demanding. WE7220B0 is the first product in our highly anticipated embedded series of products,” said Zachariah Mathews, President and CEO of Wi2Wi.

For further information, please contact:

Zachariah Mathews
President and Chief Executive Officer
408 416 4202
zach@wi2wi.com

About IoT and M2M

Essentially, IoT and M2M describe the network of physical objects or “things” embedded with electronics, software, sensors, and network connectivity, which enables these objects to collect and exchange data. Driven by several factors including the growth in the availability of Broadband Internet, which reduces the cost of connecting, and the related increase in Wi-Fi capabilities as well as sensors built into myriad technologies, this has been described as the “perfect storm” for the IoT. Almost any device with an on and off switch that can be connected to the Internet (and/or to each other) – anything from cell phones, coffee makers, washing machines, headphones, lamps, wearable devices, cars, as well as machine components in the engine of a jet airplane or the drill of an oil rig. According to analyst firm Gartner, by 2020 there will be over 26 billion connected devices. Others think this figure could be too conservative by a factor of four.

About Wi2Wi Corporation

Wi2Wi is a vertically-integrated technology company which designs, manufactures and markets high performance, low power wireless connectivity solutions, global navigation satellite system (GNSS) modules, and frequency control devices. The Company’s products and services address numerous applications in the markets of Internet of Things (IoT), Machine to Machine (M2M), Avionics, Space, and Government Sponsored Projects. Wi2Wi’s products and value-added services provide highly integrated, rugged, robust, and reliable multiprotocol wireless actuators with embedded software, along with customized timing and frequency control devices for customers, worldwide. The Company was founded in 2005 and is strategically headquartered in San Jose, California with satellite offices in Middleton, Wisconsin and Hyderabad, India. Wi2Wi’s manufacturing operations, its laboratory for reliability and quality control, together with design and engineering for timing and frequency control devices are located in Middleton, WI. The branch office, located in Hyderabad, India, focuses on the development of wireless connectivity; both hardware and software. Wi2Wi’s strategic objective is to service the unique needs of each customer by providing end to end wireless integration solutions and highly customizable timing and frequency control devices. Wi2Wi distinguishes itself from commodity grade products, with best in the market performance, highly reliable, low power wireless connectivity products with integrated software that supports broader temperature ranges and a longer product life cycle. Furthermore, Wi2Wi’s end to end product solutions helps the customer substantially reduce their end product expense, certification cost, and overall R&D investment, in addition to substantially reducing the time to market. Wi2Wi has partnered with best in class global leaders in technology, manufacturing, and sales. The Company uses a wide network of manufacturer’s representatives, worldwide, to promote its products and services, and has partnered with world class distributors for the fulfillment of orders along with direct sales.

Forward-Looking Statements: This news release contains certain forward-looking statements, including management’s assessment of future plans and operations, and the timing thereof, that involve substantial known and unknown risks and uncertainties, certain of which are beyond the Company’s control. Such risks and uncertainties include, without limitation, risks associated with the ability to access sufficient capital, the impact of general economic conditions in Canada, the United States and overseas, industry conditions, stock market volatility. The Company’s actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements and, accordingly, no assurances can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do so, what benefits, including the amount of proceeds, that the Company will derive there from. Readers are cautioned that the foregoing list of factors is not exhaustive. Additional information on these and other factors that could affect the Company’s operations and financial results are included in reports on file with Canadian securities regulatory authorities and may be accessed through the SEDAR website (www.sedar.com). Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date the statements are made and the Company undertakes no obligation to update forward-looking statements and if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable law. All subsequent forward-looking statements, whether written or oral, attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Furthermore, the forward-looking statements contained in this news release are made as at the date of this news release and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by applicable securities laws.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Wi2Wi Corporation

ReleaseID: 441039

Apple Hosting its Annual Worldwide Developers Conference

LONDON, UK / ACCESSWIRE / June 13, 2016 / ActiveWallSt.com announces its coverage of the Technology Sector with focus on the iconic electronic equipment company, Apple Inc. (NASDAQ: AAPL), as it is about to host its annual Worldwide Developers Conference (WWDC) today, Monday, June 13, 2016 in San Francisco. Coming off its first drop in quarterly revenue since 2013, the WWDC conference remains critical to understand Apple’s long-term plans, where it unveils plans for software and services changes it intends to bring to iPhone, iPad and Mac computers, as well as Apple Watch and the Apple TV. Register with us now for your free membership at:

http://www.activewallst.com/register/

Today, ActiveWallSt.com is promoting its industry and company coverage with focus on AAPL. Get all of our research for free by signing up to http://www.activewallst.com/register/.

Artificial intelligence; Siri

When Apple introduced Siri as a voice activated digital assistant on iPhone feature in 2011, it signaled a future where people instead of typing for information or completing task through different apps on their phones, can simply accomplished the same by voice command to the phone. While other virtual assistants have forged ahead, Siri has been appearing to be at a standstill.

Amazon.com Inc.(NASDAQ: AMZN), Alphabet Inc., (NASDAQ: GOOGL) owner of the Android Operating System, and Microsoft Corporation (NASDAQ: MSFT), have in recent times introduced artificial intelligence based digital assistants which work on voice command. Siri is expected to get software upgrades to improve how it understands and processes requests.

Siri is also expected to be launched on the Mac devices later this year; it is also expected to be opened to third party developers so that it becomes a household assistant working in tandem with devices or apps from other developers and companies. For Apple, the capability for Siri to connect to other apps is critical as other competitors such as Amazon’s range of speaker Alexa have successfully demonstrated this technology. In a world where devices are increasingly controlled by voice, Apple needs Siri to be a viable option, or it risks losing its grip on the fickle technology enthusiasts, which has made Apple one of the most valuable publicly traded companies in the world.

As the world is increasing moving towards ‘mobile first’ or being connected all the time, Apple understands that it has to find new ways of becoming integrated into more people’s lives irrespective of their operating system, handset or desktop preferences Apple is expected to launch a version of iMessage, its free messaging app for Android. Apple is also expected to announce redesigned features on Apple Music, its music streaming service launched last year.

Apple has been criticized in recent years for its lack of innovation and investors has punished the stock over the last year in reaction to declining sales in its flagship iPhone. Apple’s share price has declined 22.29% over the past 12 months.

The company’s newest iPhone models are expected to launch in the fall, and we should see some clues as to what to expect on the new devices. If the company can excite the market with its new products and software, expect enthusiasm to return and shares to recover its lost ground.

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
Email: info@activewallst.com
Phone number: 1-858-257-3144

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 441068

CHARLOTTE, NC / ACCESSWIRE / June 13, 2016 / Life Clips, Inc. (OTCQB: LCLP), an innovative brand of products revolutionizing the way people capture, manage, enjoy, and charge the devices that share life’s moments, today announced that in honor of the Batterfly Energy ltd. acquisition, (OTCQB: LCLP) will be giving away a free Mobeego® starter kit to all existing shareholders listed on the Company’s NOBO list, as of the close of business on Thursday, June 30, 2016.

CEO Bob Gruder said, “In everything that I do as CEO of Life Clips, I keep the shareholders in mind. This free Mobeego® starter kit giveaway is just another way of showing my appreciation for the continued support of the shareholders of (OTCQB: LCLP). Mobeego® is already sold in 14 different countries with more than 450,000 units sold! I know our shareholders will absolutely love the Mobeego® product once they try it.”

NOBO (Non-Objective Beneficial Owner) lists give companies and issuers the information of their shareholders so they can communicate regarding important shareholder communications (such as proxies, circulars for rights offerings and annual/quarterly reports) or, in this case, to send a free Mobeego® starter kit.

About Mobeego®

The Mobeego® brand launched in November 2015. Mobeego® is available within 14 different countries and has sold north of 450,000 units. Mobeego®’s anticipated revenue before the end of Q3 of this year is $1,000,000. The Mobeego product is an affordable one time use disposable battery that plugs directly into one’s mobile device, iPad, or action camera. The products can be seen at the Mobeego site: www.mobeego.com.

About Life Clips, Inc:

Life Clips is a developer and manufacturer of action cameras aimed at families, action sports enthusiasts, and those on vacation. Life Clips also offers innovative accessories like one time use batteries Mobeego® for mobile devices. Our future cameras will allow for live streaming and filming an event from more than one perspective. High quality videos and stills can be taken from unique positions.

Safe Harbor Statement

In addition to statements of current and historical fact, this Press Release contains forward-looking statements. The words “forecast,” “will,” “intend,” “anticipate,” “project,” “intend,” “expect,” “should,” “believe” and similar expressions are intended to identify forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained in this Press Release, we caution you that these statements are based on a combination of facts and factors currently known by Life Clips and its projections of the future, about which it cannot be certain. These forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors, including those discussed in “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Life Clips’ annual report on Form 10-Q and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission (the “SEC”), as well as matters discussed in Life Clips’ financial statements and related notes and other filings with the SEC, which may cause its actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Accordingly, all forward-looking statements should be evaluated with an understanding of their inherent uncertainty. Except as required by law, Life Clips assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Samsung, Iphone, GoPro, Xiaomi, are respective trademarks of Samsung, Apple, GoPro and Xiaomi. All rights reserved.

CONTACT INFORMATION:

Robert Gruder
Chief Executive Officer
info@lifeclips.com

Investor Relations

David Kugelman
Atlanta Capital Partners, LLC
(404) 856-9157
(866) 692-6847 Toll Free – U.S. And Canada

SOURCE: Life Clips, Inc.

ReleaseID: 441071

The Company Prides Itself on its Outstanding Carpet Cleaning Services, Attention to Detail and Affordable Prices

SAN DIEGO, CA / ACCESSWIRE / June 13, 2016 / The founders of Carpet Cleaning Champs, a San Diego, California-based company that provides thorough carpet cleaning services at reasonable prices, are pleased to announce the launch of their new website.

As a company spokesperson noted, the timing for the new website could not be better. Summer vacation is just around the corner, and homeowners are busy cleaning their houses in anticipation of visits from company, as well as for their children who are home from school.

The new website not only offers information about Carpet Cleaning Champs and their variety of services including rug cleaning, carpet repair, upholstery cleaning, tile and grout cleaning and more, it also features a section about the top myths surrounding professional carpet cleaning.

For example, while some homeowners might feel that scheduling a professional carpet cleaning can be a hassle, the spokesperson noted that the friendly and experienced team from Carpet Cleaning Champs is devoted to making sure the appointments are scheduled when it’s most convenient for the client.

“Professional carpet cleaners are trained to provide you the ease and comfort while they work according to your time schedule,” the spokesperson said, adding that the high quality professional cleaners from Carpet Cleaning Champs also guarantee their work. “Because we do this as a job, we are quick and efficient, which means that we’ll be out of your hair sooner than you think, leaving a soft and clean carpet behind.”

Another common myth about professional carpet cleaning, the new site noted, is that it is expensive and hard on the budget. In reality, DIY carpet cleaning can cost a lot more, especially when people take into account the machinery they have to rent or buy, the solutions they must purchase and any additional money they must pay to take care of any mistakes or do-overs.

Anybody who would like to learn more about Carpet Cleaning Champs is welcome to visit the new company website; there, they can read more about the top-quality services they provide.

About Carpet Cleaning Champs:

Carpet Cleaning Champs has a mission to provide nationwide consumers with an amazing carpet cleaning experience they can rave about to their friends and family. By refusing to use bait and switch tactics that are common in the industry, Carpet Cleaning Champs is dedicated to deliver on what they promise: top quality and affordable services that follow their strict guidelines of pleasing the customer. They also provide carpet repair, upholstery, tile/grout and rug cleaning. For more information, please visit https://carpetcleaningchamps.com/.

Carpet Cleaning Champs
6640 Lusk Blvd A108
San Diego, CA 92121

Contact:

Peter Kirkendall
info@carpetcleaningchamps.com
619-376-6056

SOURCE: Carpet Cleaning Champs

ReleaseID: 441060

SAN DIEGO, CA / ACCESSWIRE / June 13, 2016 / Global Payout, Inc. (OTC: GOHE), a leading financial provider of comprehensive and customized prepaid payment programs and e-wallet solutions announces the launch of its new website (www.globalpayout.com) declaring a move to concentrate their efforts in the FinTech Industry. Over the last 16 months, Global has secured technology partnerships with leading players in the financial technology industry and are primed to launch the next generation of their innovative financial services offerings into the marketplace.

The website outlines Global’s new financial services and technology offerings derived from their contractual relationship with ISBC Holdings Ltd., the management company for International Sovereign Bank Corporation (ISBC). The executive team at Global Payout and its partner companies have designed, and are implementing, an integrated bank portal exchange that is known as an “emerging market hub network.” This system provides a global, multi-asset exchange platform that includes a local deployment option, depository operations, surveillance software and due diligence acceptance for all accounts to meet all regulatory compliance.

The company’s next-gen FinTech technology offering is part of an overall strategy to connect customers worldwide through a banking portal structure available in every country. These country portal connections will foster foreign currency exchange, internal transfers, and commodity investments for its member customers no matter where in the world they conduct their business.

The executive team at Global Payout is excited to share these developments and invites shareholders and customers to explore the Company’s FinTech Industry at
http://globalpayout.com/industry-news.html. The website is a great resource to learn more about Global’s FinTech technology and its role in the future of banking and financial technology.

About Global Payout, Inc.:

Global Payout, Inc., www.globalpayout.com, headquartered in San Diego, California, is a processor of payments for corporate clients and their customers, members, employees, contractors, agents and suppliers worldwide and has access to processing and payment delivery platforms and networks. Global Payout is a Program Manager providing both project management advisory services and direct account provisioning systems that can be offered through Global’s eWallet platforms, digital currency management, and prepaid debit card issuing bank programs located throughout the world. This enables end-users of the platform to maximize an expanded suite of financial services and minimize operational costs through integration of state-of- the-art FinTech applications and platforms.

About ISBC Holdings Limited &
International Sovereign Banking Corporation:

International Sovereign Banking Corporation (ISBC), a privately held Native American Corporation, has plans to provide access to global Private banking services with secure and customized private commercial and merchant banking accounts through its planned banking Portal structures. ISBC Holdings Limited, the sole manager of ISBC, was established by the executive leadership of Denovo Formations, Inc., Capital Growth Planning, Inc., and Prime Domain International, Inc., with a banking charter that has been issued for both US and International operations to allow for private banking solutions to be offered to the widest range of banking customers and services. In addition to normal banking services planned, ISBC will operate several advanced data processing and IT platforms for deposits, remittance, and settlement of banking products and services utilizing the newest FinTech applications and platforms. This is part of an overall Private Banking Strategy to connect customers and transactions worldwide through its planned banking Portal structures to be developed and placed in each country.

Forward-Looking Statements
Disclosure:

This press release may contain “forward-looking statements” within the meaning of the federal securities laws. In this context, forward looking statements may address the Company’s expected future business and financial performance, and often contain words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “seeks,” “will” and other terms with similar meaning. These forward-looking statements by their nature address matters that are, to different degrees, uncertain. Although the Company believes that the assumptions upon which its forward looking statements are based are reasonable, it can provide no assurances that these assumptions will prove to be correct. All forward-looking statements in this press release are expressly qualified by such cautionary statements, risk, and uncertainties, and by reference to the underlying assumptions.

CONTACT:

Global Payout, Inc.
Investor Relations
info@GlobalPayout.com

SOURCE: Global Payout Inc.

ReleaseID: 441054

BALTIMORE, MD / ACCESSWIRE / June 13, 2016 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has released a research report on Abattis Bioceuticals Corp. (OTC: ATTBF) (CSE: ATT), a specialty biotechnology poised to help transform two fast-growing segments of the health and wellness arenas.

A bird’s eye view of the Company reveals a holding company that aggregates, incubates, develops, and integrates complementary late venture stage entities and their offerings into
autonomous yet related divisions. Management has set the stage for Abattis to enjoy substantial revenue growth via a multi-pronged revenue generation approach, including IP Licensing. This strategy includes initially building sales in traditional specialty markets with its broad line of conventional health and wellness products followed by the hockey-stick type growth associated with the cannabis space in North America.

In the research report, analyst Rob Goldman discusses the Company’s unique market positioning, and enviable growth prospects.

Goldman noted, “With sales commencing in 3Q16, Abattis is transforming itself from an R&D entity into a well-positioned revenue-generating company that is an emerging player in the multi-billion dollar nutraceutical and functional foods markets. In the near term, ATTBF is on track to offer a variety of innovative products based on its proprietary Health Canada approved formulations and its portfolio of licensed Natural Product Number (NPN) ingredients which are proven to offer health benefits to consumers. ATTBF plans to offer future products containing cannabinoid ingredients which many medical practitioners believe can help treat a variety of ailments.”

“In the next revenue stage, which could generate hockey-stick type growth, the NVL unit promises to emerge as a premier and rare analytical testing lab, as well as an R&D partner to the legal medical cannabis industry in Canada when commercial operations commence in 2H16. NVL has applied for a Controlled Substance License with Health Canada for the possession of cannabis, and extracts production analysis. Its CSL is pending with final site inspections completed in June 2016. Potentially serving as one of an elite few to perform tests on cannabis ingredients on behalf of production companies is a huge advantage for this emerging entity,” Goldman further commented.

Goldman believes that ATTBF boasts an enviable leadership team with deep marketing experience. “With no long term debt and an improved balance sheet and capital structure, ATTBF is primed to enjoy substantial sales growth. Leveraging its multi-pronged approach and exposure to fast-growing multi-billion dollar markets, we believe ATTBF’s market value is significantly undervalued with a major re-valuation set to occur this year, based in part on the Company’s standing vis-à-vis a key comparable.”

About Goldman Small Cap Research: Founded in 2009 by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and microcap stock research reports, articles, daily stock market blogs, and popular investment newsletters. Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.

This press release contains excerpts of our most recently published sponsored research report on Abattis Bioceuticals Corp. which carries a rating and a price target. The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research relied solely upon information derived from Abattis Bioceuticals Corp. (“the Company”) authorized press releases or legal disclosures made in its filings with the U.S. Securities and Exchange Commission http://www.sec.gov.

Separate from the factual content of our report about the Company, we may from time to time include our own opinions about the Company, its business, markets and opportunities. Any opinions we may offer about the Company are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results.

A Goldman Small Cap Research report, update, newsletter, article, or press release is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed is to be used for informational purposes only. Please read all associated full disclosures, disclaimers, and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other agency. To download this sponsored research report or any of our research, view our disclosures and disclaimers, or for more information, visit www.goldmanresearch.com. Goldman Small Cap Research has been compensated by the Company in the amount of $6000 for a research subscription service.

About Abattis Bioceuticals Corp.: Abattis Bioceuticals Corp. (OTCQB – ATTBF) is a specialty biotechnology company that aggregates, incubates, integrates, and invests in the botanical drug development industry. The Company develops and licenses natural health products, medicines, extractions, and ingredients for the nutraceutical, bioceutical, and functional foods markets. Current product development strategy is focused on high-quality conventional botanical products. Future product development is expected to include new products containing cannabinoid compounds.

Learn more about ATTBF at www.Abattis.com

Goldman Small Cap Research
Rob Goldman, Analyst
410-609-7100
rob@goldmanresearch.com

SOURCE: Goldman Small Cap Research

ReleaseID: 441056

Data Published in the Journal of Critical Care Supports the Potential of Neutrolin® as a Non-antibiotic Antimicrobial Solution

BEDMINSTER, NJ / ACCESSWIRE / June 13, 2016 / CorMedix Inc. (NYSE MKT: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, announced today publication of a research article highlighting the increased cost and mortality associated with bloodstream infections (“BSI”) following placement of a central venous catheter (“CVC”). CorMedix’s non-antibiotic anti-infective solution Neutrolin® is in Phase 3 clinical development in the U.S. for preventing catheter-related bloodstream infections. Neutrolin demonstrated greater than 96% reduction in infection rate compared to historical benchmarks in an observational study conducted in Europe where Neutrolin is a CE Marked product.

The article titled, “Clinical and Economic Burden of Bloodstream Infections Following Central Venous Catheter Placement in the Intensive Care Unit” will be published in the Journal of Critical Care and is currently available online ahead of print. The study was conducted by DaVita Clinical Research and was presented recently at 21st Annual International Society for Pharmacoeconomics and Outcomes Research Meeting in Washington, DC.

Randy Milby, CorMedix CEO, said, “This research underscores the importance of our work as we pursue the current U.S. Phase 3 clinical trial evaluating the safety and efficacy of Neutrolin for the prevention of catheter-related bloodstream infections and maintenance of catheter patency in CVCs used for vascular access in hemodialysis patients. Currently, there are no pharmacological agents approved in the United States for the prevention of catheter related bloodstream infections. At the same time, data indicates that catheter related bloodstream infections are associated with significant increases in costs of care and risk of death during initial hospitalization.”

The study analyzed patients who had an index hospitalization involving an Intensive Care Unit stay between January 1, 2011 and September 30, 2014 wherein a CVC was placed. Comparisons were made between patients who developed bloodstream infections following CVC insertion (n=522) and those who did not (n=1441). Length of hospital stay, billed costs of the index hospitalization, and total healthcare costs incurred over the 180-day period following discharge were compared, in addition to in-hospital mortality and 30-day readmission rates. The study found that development of BSI (versus not) was associated with longer hospital stay: 15.4 versus 8.6 days, respectively, and greater costs for the index hospitalization, $296,933 versus $188,387, respectively. Development of BSI was associated with a more than 3-fold greater mortality rate, corresponding to an adjusted incidence rate difference of 15.5%.

Full text of the article can be found by visiting the Journal of Critical Care website here: http://www.jccjournal.org/article/S0883-9441%2816%2930068-5/abstract.

About CorMedix Inc.

CorMedix Inc. is an emerging commercial-stage biopharmaceutical company that initiated a Phase 3 clinical study of a novel anti-infective solution Neutrolin in hemodialysis patients in the United States in December 2015. The Company seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of infectious and inflammatory diseases. CorMedix’s first commercial product in Europe is Neutrolin®, a catheter lock solution for the prevention of catheter related bloodstream infections and maintenance of catheter patency in tunneled, cuffed, central venous catheters used for vascular access in hemodialysis patients, in addition to oncology patients, critical care patients, and patients receiving total parenteral nutrition, IV hydration, and/or IV medications. The FDA has granted Fast Track status to Neutrolin Catheter Lock Solution and also has designated Neutrolin as a Qualified Infectious Disease Product for oncology, hemodialysis, and critical care/intensive care patients, where catheter-related blood stream infections and clotting can be life-threatening. The initial and planned indications aim to address significant needs in catheter-based treatments in the U.S. and the rest of the world. For more information visit: www.cormedix.com.

For Investors & Media:
Tiberend Strategic Advisors, Inc.
Joshua Drumm, Ph.D.: jdrumm@tiberend.com; (212) 375-2664
Janine McCargo: jmccargo@tiberend.com; (646) 604-5150

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. All statements, other than statements of historical facts, regarding management’s expectations, beliefs, goals, plans or CorMedix’s prospects, future financial position, financing plans, future revenues and projected costs should be considered forward-looking. Readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors, including: the results of studies regarding Neutrolin® conducted by us and others; the cost, timing and results of the planned Phase 3 trials for Neutrolin® in the U.S.; obtaining regulatory approvals to conduct clinical trials and to commercialize CorMedix’s product candidates, including marketing of Neutrolin in countries other than Europe; obtaining additional financing to support CorMedix’s research and development and clinical activities and operations; the risks associated with the launch of Neutrolin in new markets; CorMedix’s ability to enter into, execute upon and maintain collaborations with third parties for its development and marketing programs; CorMedix’s ability to maintain its listing on the NYSE MKT; the risks and uncertainties associated with CorMedix’s ability to manage its limited cash resources; the outcome of clinical trials of CorMedix’s product candidates and whether they demonstrate these candidates’ safety and effectiveness; CorMedix’s ability to identify and enter into strategic transactions; CorMedix’s dependence on its collaborations and its license relationships; achieving milestones under CorMedix’s collaborations; CorMedix’s dependence on preclinical and clinical investigators, preclinical and clinical research organizations, manufacturers, sales and marketing organizations, and consultants; and protecting the intellectual property developed by or licensed to CorMedix. These and other risks are described in greater detail in CorMedix’s filings with the SEC, copies of which are available free of charge at the SEC’s website at www.sec.gov or upon request from CorMedix. CorMedix may not actually achieve the goals or plans described in its forward-looking statements, and investors should not place undue reliance on these statements. CorMedix assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

SOURCE: CorMedix Inc.

ReleaseID: 441069